Effects of the appetite-inducing hormone ghrelin on decision making in healthy volunteers

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517598-26-00

Acronym

GHREDECIDE

Enrollment

Registered

2024-10-21

Start date

2019-08-26

Completion date

2025-08-13

Last updated

2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gambling disorder

Brief summary

The dependent variable will be the total number of spins the participant carries out in the Slot Machine task.

Detailed description

The dependent variable will be the proportion of trials in which the participant gambled, i.e.; chose the option with an uncertain over that with a certain outcome in the Gambling Task., The dependent variable will be the mean number of pumps per trial, excluding trials where the balloon explodes in the Balloon Analog Risk Task..

Interventions

DRUG0.9% Sodium Chloride Intravenous Infusion Solution

DRUGAcyl Ghrelin 0.25 mg

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
The dependent variable will be the total number of spins the participant carries out in the Slot Machine task.	—

Secondary

Measure	Time frame
The dependent variable will be the proportion of trials in which the participant gambled, i.e.; chose the option with an uncertain over that with a certain outcome in the Gambling Task., The dependent variable will be the mean number of pumps per trial, excluding trials where the balloon explodes in the Balloon Analog Risk Task..	—

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026